TrialPanorama/TrialPanorama-database huggingface dataset:
Study: NCT06118177

Intervention type: PROCEDURE
Intervention: connective tissue harvesting
Description: The subepithelial connective tissue graft was obtained in each patient using the single incision technique from the region between the mesial of canine and the mesial of first molar in the palate. Connective tissue dimensions were approximately 10 × 5 × 2 mm. Finally, the incision line was sutured with 5/0 synthetic, nonabsorbable, sterile monofilament suture

Intervention type: PROCEDURE
Intervention: connective tissue harvesting
Description: The subepithelial connective tissue graft was obtained in each patient using the single incision technique from the region between the mesial of canine and the mesial of first molar in the palate. Connective tissue dimensions were approximately 10 × 5 × 2 mm. Finally, the incision line was sutured with 5/0 synthetic, nonabsorbable, sterile monofilament suture

Intervention type: DIAGNOSTIC_TEST
Intervention: ultrasonography
Description: A 6-18 MHz intraoral probe was used in intraoral USG examinations. Sterile gel was applied to the intraoral probe and covered with a stretch film. Then, it was placed directly on the mucosal surface of the donor site in the palatal area. Mucosal thickness was evaluated using the B-mode of the device, and vascularization was evaluated using the color doppler and pulsed wave doppler modes of the device. The following equation is used and calculated by US unit: Pulsality index (PI) = (Vmax-Vmin)/(Vmean) (Vmax is peak systolic flow velocity, Vmin is diastolic flow velocity and Vmean is mean flow velocity). The mean PI values of each patient were measured.

Intervention type: DIAGNOSTIC_TEST
Intervention: ultrasonography
Description: A 6-18 MHz intraoral probe was used in intraoral USG examinations. Sterile gel was applied to the intraoral probe and covered with a stretch film. Then, it was placed directly on the mucosal surface of the donor site in the palatal area. Mucosal thickness was evaluated using the B-mode of the device, and vascularization was evaluated using the color doppler and pulsed wave doppler modes of the device. The following equation is used and calculated by US unit: Pulsality index (PI) = (Vmax-Vmin)/(Vmean) (Vmax is peak systolic flow velocity, Vmin is diastolic flow velocity and Vmean is mean flow velocity). The mean PI values of each patient were measured.

Intervention type: OTHER
Intervention: autolog platelet rich fibrin application
Description: Leukocyte rich PRF (L-PRF) was obtained with the centrifugation of the two tubes at 2800 rpm for 12 minutes. After centrifugation, L-PRF clots were taken from the tubes using sterile tweezers, separated from the red blood cell base using scissors. Then L-PRF membrane was placed into the donor site.
Study: NCT05352971

Intervention type: OTHER
Intervention: Biomarker quantification
Description: Patient blood samples will be tested on 2 different platforms
Study: NCT06258317

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: fixation of conventional polypropylene mesh
Description: By fixation of the polyprolene mesh,patients will be divided into two groups:~Group 1 includes patients with fixation of conventional polypropylene mesh. Group 2 includes patients without fixation of the mesh.

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: fixation of conventional polypropylene mesh
Description: By fixation of the polyprolene mesh,patients will be divided into two groups:~Group 1 includes patients with fixation of conventional polypropylene mesh. Group 2 includes patients without fixation of the mesh.
Study: NCT05710198

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Citicoline eye drops 2%
Description: Eye drops containing Citicoline 2%

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Eye drops containing placebo matching product
Study: NCT06544252

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Low glycaemic index rice-based mixed meal (GI value = 47)
Description: The mixed meal consisted of Basmati rice, chicken, and green-leafy vegetables. The energy content of the mixed meal was based on the body mass of the participant. The amount of CHO was 1.3 g.kg-1 body mass (Burke et al. 2019), and the amount of protein given was 0.5 g.kg-1 per meal (Witard, Garthe and Phillips 2019).

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Low glycaemic index rice-based mixed meal (GI value = 47)
Description: The mixed meal consisted of Basmati rice, chicken, and green-leafy vegetables. The energy content of the mixed meal was based on the body mass of the participant. The amount of CHO was 1.3 g.kg-1 body mass (Burke et al. 2019), and the amount of protein given was 0.5 g.kg-1 per meal (Witard, Garthe and Phillips 2019).

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: High glycaemic index rice-based mixed meal (GI value = 80)
Description: The mixed meal consisted of fragrant rice, chicken, and green-leafy vegetables.The energy content of the mixed meal was based on the body mass of the participant. The amount of CHO was 1.3 g.kg-1 body mass (Burke et al. 2019), and the amount of protein given was 0.5 g.kg-1 per meal (Witard, Garthe and Phillips 2019).

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: High glycaemic index rice-based mixed meal (GI value = 80)
Description: The mixed meal consisted of fragrant rice, chicken, and green-leafy vegetables.The energy content of the mixed meal was based on the body mass of the participant. The amount of CHO was 1.3 g.kg-1 body mass (Burke et al. 2019), and the amount of protein given was 0.5 g.kg-1 per meal (Witard, Garthe and Phillips 2019).
Study: NCT04703257

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Metamizole
Description: Patients in the experimental group will be instructed to take metamizole 1000 mg orally three times a day for four days patients will be instructed to take 1000 mg paracetamol orally four times a day for four days. .

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Patients in the control group will be instructed to take a placebo tablet three times a day for four days and patients will be instructed to take 1000 mg paracetamol orally four times a day for four days.
Study: NCT04520074

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Etoposide, Cyclophosphamide, Carboplatin/Cisplatin
Description: CTX 400mg（250mg/m2）+VP-16 100mg (70mg/m2)d1-d3 iv 4w/6cycles , CBP(AUC=5) d1/CDDP 30mg/m2 d1-d2+CTX 600mg(400mg/m2)d1-d2 iv 8w/6cycles
Study: NCT05029349

Intervention type: DEVICE
Group type: OTHER
Intervention: VOC analysis
Description: VOC analysis in exhaled air with e-noses and mass spectrometry.
Study: NCT05951621

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Qigong
Description: An ancient Chinese system of postures, exercises, breathing techniques, and meditations designed to improve and enhance the body's QI.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: guidance of nutrition and exercise
Description: Provide health promotion and guidance to participants on diet and physical exercise
Study: NCT06298968

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: combined therapy using gemcitabine and cisplatin chemotherapy, Lenvatinib and Adebrelimab
Description: Gemcitabine (1000mg/m²) and cisplatin (25mg/m²) on day1 and 8 every 3 weeks, with a total of 6 cycles.~Lenvatinib 8 mg once daily (QD) oral dosing, continuous use for 2 years. Adebrelimab 1200mg intravenously every 3 weeks, continuous use for 2 years.
Study: NCT06240546

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: LPM6690176
Description: Administered orally

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: LPM6690176
Description: Administered orally

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: LPM6690176
Description: Administered orally

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: LPM6690176
Description: Administered orally

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: LPM6690176
Description: Administered orally

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: LPM6690176
Description: Administered orally

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: LPM6690176
Description: Administered orally
Study: NCT05674383

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Axillary plexus nerve block
Description: Axillary plexus nerve block: an ultrasound-guided axillary plexus nerve block with a single injection of lidocaine 1%.

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Fracture hematoma block
Description: Fracture hematoma block: a blinded single injection into the fracture with lidocaine 1%.
Study: NCT06437054

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Dexamethasone
Description: Dexamethasone 5mg/ml

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Dexamethasone
Description: Dexamethasone 5mg/ml

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Hyaluronic acid
Description: Hyaluronic Acid 20mg/2ml

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Indocyanine green(ICG)
Description: ICG 25mg

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Indocyanine green(ICG)
Description: ICG 25mg
Study: NCT05896137

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: CS0159 2mg
Description: Oral QD

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: CS0159 2mg
Description: Oral QD

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo
Description: Oral QD

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo
Description: Oral QD
Study: NCT05725044

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Ginsengberry concentrate
Description: Ginsengberry concentrate

Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo
Study: NCT05077241

Intervention type: DEVICE
Group type: PLACEBO_COMPARATOR
Intervention: Inspiratory muscle training
Description: Individuals will be instructed to perform a rapid contraction of the inspiratory muscles against a load and sustain it for 2 seconds in each maneuver.

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Inspiratory muscle training
Description: Individuals will be instructed to perform a rapid contraction of the inspiratory muscles against a load and sustain it for 2 seconds in each maneuver.
Study: NCT05367882

Intervention type: DIAGNOSTIC_TEST
Intervention: ELISA
Description: collection of blood samples from critically ill COVID-19 patients, then serum samples are collected after centrifugation measuring IL-6, IL-10 and IP-10 by ELISA
Study: NCT06426160

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Tocilizumab 20 MG/ML [Actemra]
Description: Tocilizumab 8 mg/kg every four weeks for 24 weeks.

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Sodium Chloride 0.9% Inj
Description: Placebo (Sodium chloride) every four weeks for 24 weeks.
Study: NCT05490433

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: robot assisted nipple sparing mastectomy(RNSM)
Description: Patients receiving RNSM and IBR are enrolled in this group. The RNSM is performed using a robotic surgical system.~The robotic surgical system includes da Vinci S, Si, X, Xi, and SP Systems. An armpit or lateral chest incision is used in this surgical procedure. A lateral chest incision is used. Posterior flow tissue collection is recommended for frozen segment biopsy during surgery. If a suspected lesion is observed on the superficial or posterior interface during surgery, a frozen section for that lesion. Biopsy is recommended. For NAC, superficial edges, and/or posterior edges in frozen intercept biopsy, If tumor invasion is identified, additional resection or postoperative radiotherapy, including skin and NAC, should be considered do. In IBR, tissue extensor insertion, prosthesis insertion, photolateral sheath, transverse abdominal rectangular sheath, or deep lower abdominal perforated vessels. The skin plate is applicable.

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Conventional nipple sparing mastectomy(CNSM)
Description: Patients who receive CNSM and IBR are enrolled in this group. CNSM uses a robot or endoscopic surgical system Do not travel. All kinds of skin incisions can be performed in this technique. It is recommended to collect posterior mammary gland tissue for frozen segment biopsy during surgery. If a lesion suspected of tumor invasion is observed at the edge of the surface or posterior edge during surgery, a freeze-intercept biopsy is recommended for that lesion.~If a frozen segment biopsy identifies invasion of tumors on NAC, superficial edges, and/or posterior edges, further resection or postoperative radiotherapy, including skin and NAC, is considered.~In IBR, tissue extensor insertion, prosthesis insertion, photomultiplier sheath, transverse rectangular sheath, or deep lower abdominal perforated vessels.~It includes a sheath. It is excluded if there is no IBR.
Study: NCT05543031

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Music-Integrated Phonological Awareness training program
Description: We would like to observe the effect of the music integrated phonological awareness program on preschool cochlear implant users and to compare the phonological awareness skills of the study group with the control group before and after the online training. The program is prepared as 10 lessons. Participants were guided through online training for 5 weeks, with 20-minute sessions conducted weekly. The training was carried out via Zoom, a free virtual interview program. Each family had a computer.

Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Spectral-Temporally Modulated Ripple Test (SMRT)
Description: Spectral-Temporally Modulated Ripple Test (SMRT) was used to assess the spectral discrimination ability of the study group.Speech stimuli were presented at a calibrated presentation level of 60 dB SPL in a quiet room. The child was positioned at 0° azimuth and 1-meter from the loudspeaker.

Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: The Phonological Awareness Scale of Early Childhood Period (PASECP)
Description: The Phonological Awareness Scale of Early Childhood Period (PASECP) was used to measure the sound awareness and sound discrimination skills of study group pre-post training. The test has 8 sub-dimensions.

Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: The Phonological Awareness Scale of Early Childhood Period (PASECP)
Description: The Phonological Awareness Scale of Early Childhood Period (PASECP) was used to measure the sound awareness and sound discrimination skills of study group pre-post training. The test has 8 sub-dimensions.

Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Mismatch Negativity Test
Description: Mismatch Negativity (MMN) was used to evaluate the central auditory system.The test was used for electrophysiological recordings of the study group.The standard stimulus presented as /ba/ (%80), and the rare stimulus presented as /da/ (%20) frequency. The onset (rise) and offset (fall) times of the stimuli are 10 ms, and the plateau time is 50 ms. The interval between stimuli for both responses was 1.1 ms. A 0.1-30 Hz filter was applied. The speech stimuli intensity was 70 dB SPL. Speech stimuli were presented at a 1-meter distance from the participant, with speakers placed at an angle of 0°.

Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Early Language Development (TELD-3)
Description: Test of Early Language Development (TELD-3) measured children's receptive and expressive language skills both group for inclusion criteria.

Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Early Language Development (TELD-3)
Description: Test of Early Language Development (TELD-3) measured children's receptive and expressive language skills both group for inclusion criteria.
Study: NCT06509789

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Transcranial magnetic stimulation (TMS) - Theta burst stimulation (TBS) protocol
Description: This procedure uses magnetic fields to stimulate nerve cells in the brain involved in various neurological functions, such as motor control. Theta burst stimulation is a patterned form of TMS protocol.
Study: NCT06003023

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Physical Activity Monitoring
Description: A physical activity monitor (Fitbit) will be provided to participants in both arms.

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Physical Activity Monitoring
Description: A physical activity monitor (Fitbit) will be provided to participants in both arms.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Tailored Exercise Prescription
Description: Participants in both arms will receive the results of their exercise stress test, which includes information on the duration, frequency, and intensity of their physical activity.

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Tailored Exercise Prescription
Description: Participants in both arms will receive the results of their exercise stress test, which includes information on the duration, frequency, and intensity of their physical activity.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Healthy Lifestyle Education
Description: Participants in both arms will receive information on healthy living, including topics such as physical activity, sleep, stress management, and diet.

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Healthy Lifestyle Education
Description: Participants in both arms will receive information on healthy living, including topics such as physical activity, sleep, stress management, and diet.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Physical Activity Lifestyle Intervention Informed by the Theory of Planned Behavior
Description: Participants randomized to the CHD-PAL arm will receive coaching to: 1) change attitudes towards physical activity; 2) increase perceptions of other people's approval of physical activity; 3) increase perceptions of control over being physically active. These elements will be delivered using a non-judgmental stance and will be accompanied by goal-setting.
Study: NCT05542121

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Robot-Assisted Therapy with Rehab CARES system
Description: 60 min sessions; 3 sessions per week; for 4 weeks; Patients uses 1 or more affordable robots to exercise the UL with adaptive games assessments as OT; standard of care PT and SLP; Subjects' motor and cognitive impairment will be used to set the game and modes. The game parameters will be adjusted according to motor and cognitive impairment of that station's user while the controller will automatically adjust assisting or resisting torques experienced. The 60 minutes will be broken up into 15-minute training intervals.

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Standard of Care
Description: 60 min sessions; 3 sessions per week; for 4 weeks of OT, PT, and SLP
Study: NCT06471907

Intervention type: PROCEDURE
Group type: PLACEBO_COMPARATOR
Intervention: erector spinae plane block
Description: fascial plane injection using ultrasound

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: erector spinae plane block
Description: fascial plane injection using ultrasound
Study: NCT06509789

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Transcranial magnetic stimulation (TMS) - Theta burst stimulation (TBS) protocol
Description: This procedure uses magnetic fields to stimulate nerve cells in the brain involved in various neurological functions, such as motor control. Theta burst stimulation is a patterned form of TMS protocol.

Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: Transcranial magnetic stimulation (TMS) - Theta burst stimulation (TBS) protocol
Description: This procedure uses magnetic fields to stimulate nerve cells in the brain involved in various neurological functions, such as motor control. Theta burst stimulation is a patterned form of TMS protocol.
Study: NCT04787289

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Bevacizumab
Description: Low standard dose of bevacizumab, combined with single agent chemotherapy (7.5mg/kg IV Q3w or 5mg/kg IV Q2w)

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Bevacizumab
Description: Low standard dose of bevacizumab, combined with single agent chemotherapy (7.5mg/kg IV Q3w or 5mg/kg IV Q2w)
Study: NCT06477276

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Nervio-X
Description: An 8-channel TIS device developed by NEURODOME Corporation.

Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: Nervio-X
Description: An 8-channel TIS device developed by NEURODOME Corporation.
Study: NCT05530980

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: GameDay Ready Program
Description: GameDay Ready is a 12-week, group-based behavioral weight management program in which participants will meet in-person once per week at a publicly accessible walking track. Each weekly session will be led by a trained facilitator and will include a brief educational component, participant updates on progress, group discussions about overcoming barriers, supervised competitive physical activities, and goal setting for the upcoming week. Educational content will be reinforced and social support will be provided during warmup and cool down walks. Participants will be asked to set behavioral goals toward increasing physical activity and improving dietary habits and will be provided resources to self-monitor their activity, dietary intake, and weight.